tiprankstipranks
Advertisement
Advertisement

PRAX Stock Latest News

Praxis Extends Vormatrogine Epilepsy Trial, Keeping Long-Term Growth Story in Play
Company AnnouncementsPraxis Extends Vormatrogine Epilepsy Trial, Keeping Long-Term Growth Story in Play
1d ago
PRAX
Praxis Advances PRAX-628 Tablet Formulation in Completed Bioavailability Study
PremiumCompany Announcements
Praxis Advances PRAX-628 Tablet Formulation in Completed Bioavailability Study
1d ago
PRAX
Praxis Precision initiated with a Buy at Goldman Sachs
PremiumThe Fly
Praxis Precision initiated with a Buy at Goldman Sachs
23d ago
PRAX
Praxis Precision, Remagine Labs Partner on Ulixacaltamide Patch
PremiumCompany Announcements
Praxis Precision, Remagine Labs Partner on Ulixacaltamide Patch
28d ago
8K
PRAX
Praxis Precision, Remagine Labs announce research collaboration and license pact
PremiumThe Fly
Praxis Precision, Remagine Labs announce research collaboration and license pact
29d ago
PRAX
Raymond James Analyst Maintains Buy on Praxis, Sees PDUFA Extension as Manageable While Trimming Price Target from $731 to $719
PremiumRatingsRaymond James Analyst Maintains Buy on Praxis, Sees PDUFA Extension as Manageable While Trimming Price Target from $731 to $719
1M ago
PRAX
FDA Extends Review Timeline for Praxis’ Relutrigine NDA
Premium
Company Announcements
FDA Extends Review Timeline for Praxis’ Relutrigine NDA
1M ago
8K
PRAX
Praxis Precision price target raised to $575 from $510 at Needham
Premium
The Fly
Praxis Precision price target raised to $575 from $510 at Needham
1M ago
PRAX
Praxis Wins FDA Breakthrough Status for Elsunersen Epilepsy Drug
PremiumCompany Announcements
Praxis Wins FDA Breakthrough Status for Elsunersen Epilepsy Drug
1M ago
8K
PRAX
Praxis Precision granted breakthrough therapy designation for elsunersen
PremiumThe Fly
Praxis Precision granted breakthrough therapy designation for elsunersen
1M ago
PRAX
Praxis Precision initiated with an Outperform at RBC Capital
PremiumThe Fly
Praxis Precision initiated with an Outperform at RBC Capital
2M ago
PRAX
Praxis Precision Medicines Shareholders Back Directors and Governance
PremiumCompany Announcements
Praxis Precision Medicines Shareholders Back Directors and Governance
2M ago
8K
PRAX
Praxis Precision management to meet with Piper Sandler
PremiumThe FlyPraxis Precision management to meet with Piper Sandler
2M ago
PRAX
Praxis Precision falls -15.4%
Premium
The Fly
Praxis Precision falls -15.4%
2M ago
PRAX
Praxis Precision price target lowered to $616 from $715 at Truist
Premium
The Fly
Praxis Precision price target lowered to $616 from $715 at Truist
2M ago
PRAX
Praxis Precision price target lowered to $650 from $750 at Oppenheimer
PremiumThe Fly
Praxis Precision price target lowered to $650 from $750 at Oppenheimer
2M ago
PRAX
Praxis Precision price target lowered to $162 from $166 at Wedbush
PremiumThe Fly
Praxis Precision price target lowered to $162 from $166 at Wedbush
2M ago
PRAX
Praxis Precision price target lowered to $810 from $843 at BTIG
PremiumThe Fly
Praxis Precision price target lowered to $810 from $843 at BTIG
2M ago
PRAX
Praxis Precision price target lowered to $400 from $433 at Baird
PremiumThe Fly
Praxis Precision price target lowered to $400 from $433 at Baird
2M ago
PRAX
Buy Rating Reaffirmed as Higher Relutrigine Pricing Assumptions Offset Vormatrigine Setback; $537 Price Target Maintained
PremiumRatingsBuy Rating Reaffirmed as Higher Relutrigine Pricing Assumptions Offset Vormatrigine Setback; $537 Price Target Maintained
2M ago
PRAX
Yazdi Maintains Buy on Praxis, Trims Price Target to $810 as Vormatrigine Outlook Softens but Core Pipeline Thesis Remains Intact
Premium
Ratings
Yazdi Maintains Buy on Praxis, Trims Price Target to $810 as Vormatrigine Outlook Softens but Core Pipeline Thesis Remains Intact
2M ago
PRAX
Praxis Precision price target lowered to $1,201 from $1,245 at H.C. Wainwright
Premium
The Fly
Praxis Precision price target lowered to $1,201 from $1,245 at H.C. Wainwright
2M ago
PRAX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >